Delivery Order SPE2DR25D3104-SPE2DR26FE8YM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,864.31 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injections on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,499.81 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections. The contract, executed on November 14, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections, with a firm fixed price ceiling value of $1,088.36. This non-competitive, competitively awarded delivery order is set to be completed by September 19, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections valued at $4,054.86 under a firm fixed-price contract with an ultimate completion date of December 10, 2025. This non-set-aside award was issued competitively and represents a specific pharmaceutical procurement supporting federal healthcare operations. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injections valued at $7,983.73 on December 3, 2025, with completion expected by December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's established relationship with DLA as a critical pharmaceutical distributor supporting federal medical procurement. The work will be performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injections with a ceiling value of $1,788.12. This is a firm fixed price delivery order with an ultimate completion date of December 23, 2025, awarded on December 22, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery order is a child contract...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injections, valued at $1,576.70 with a firm fixed price structure. This non-competitive delivery order, issued on December 1, 2025, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. The award represents a standard pharmaceutical supply transaction supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections, with a contract ceiling value of $2,720.90 and a completion date of June 26, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,217.65 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This firm fixed price, non-set-aside delivery order was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement supporting federal medical...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE8YMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injections valued at $3,757.66, with a completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply support under AmerisourceBergen's existing relationship with the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through competitively awarded delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 12/7/25 |